Pharmaceutical – Page 11 – Healthy Skeptic

Feb 10 2010

Washington Post

By Kevin Roche Headlines No Comments

Merck & Co. must appoint two new independent committees and a chief medical officer to monitor the safety of its medicines and drugs in development, under a proposed settlement

Feb 09 2010

Washington Post

By Kevin Roche Headlines No Comments

A bipartisan group of congressional members outlined a number of allegations against CVS Caremark – the group urged the FTC to investigate the company

Feb 09 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Now, AstraZeneca’s statin Crestor has crossed a new threshold: It’s the cholesterol drug for people who don’t have high cholesterol.

Feb 08 2010

Bloomberg

By Kevin Roche Headlines No Comments

Insurers, drugmakers and hospitals will likely slash costs and merge companies to maneuver through a U.S. health-care landscape

Feb 05 2010

New York Times

By Kevin Roche Headlines No Comments

With the health care overhaul on a back burner, drug makers are getting a sinking sense of how a piecemeal public policy future might look for them

Jan 29 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Novartis agreement to settle allegations involving marketing of an epilepsy drug is the latest in a string of cases showing that improper marketing practices are still a problem

Jan 29 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

The chairman of the drug industry’s main trade group in the U.S. said the group “hasn’t withdrawn support” for the version of health-care reform passed by the Senate

Jan 27 2010

Washington Times

By Kevin Roche Headlines No Comments

A House panel on Wednesday will consider shining a light on White House deals made with special-interest groups during the push to pass a health care reform bill.

Jan 26 2010

Shifts in Drug Marketing Spending

By Kevin Roche Commentary No Comments

Pharmaceutical manufacturers have spent massive amounts of money on sending sales reps to visit individual physicians and on direct-to-consumer advertising, to the point that this spending is often larger than…

Read More

Jan 21 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Republican Senate victory caught many health-care companies off guard – some reiterated support Wednesday for a sector overhaul

Jan 20 2010

Bloomberg

By Kevin Roche Headlines No Comments

Drugmakers’ shares posted the biggest gains in Asia and Europe today on speculation Obama’s plan to overhaul the health-care system will be derailed

Jan 19 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Despite years of effort to make medications safer medication errors cause at least one death every day and injure approximately 1.3 million people annually

Jan 15 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

Walgreen Co. warned it will withdraw about half of its pharmacies from the state of Washington’s Medicaid as the program continues to cut back on reimbursements

Jan 15 2010

Washington Post

By Kevin Roche Headlines No Comments

A LOOPHOLE in existing law allows manufacturers of brand-name drugs to pay competitors to keep cheaper, generic versions off the market

Jan 13 2010

Wall Street Journal

By Kevin Roche Headlines No Comments

People with Type 2 diabetes will have an opportunity for personal consultations with Walgreen Co. pharmacists and nurse practitioners under a pilot program

© 2025 Healthy Skeptic.